m⁶A RNA Modification: Technologies Behind Future Anti-Cancer Therapy

Area of Science:

• Epigenetics
• Molecular Biology
• Cancer Biology

Background:

• N6-methyladenosine (m⁶A) is a prevalent RNA epigenetic modification.
• m⁶A regulates RNA metabolism and is implicated in cancer pathogenesis.
• Dysregulation of m⁶A dynamics contributes to tumor progression and drug resistance.

Purpose of the Study:

• To review recent advances in targeting the m⁶A machinery for cancer therapy.
• To evaluate strategies for modulating m⁶A levels and enzyme activity.
• To identify effective approaches for restoring m⁶A homeostasis in cancer.

Main Methods:

• Review of current literature on m⁶A targeting strategies.
• Analysis of small-molecule inhibitors, antisense oligonucleotides, and CRISPR/Cas-based tools.
• Evaluation of methods for writing, erasing, and altering m⁶A marks.

Main Results:

• Various therapeutic strategies targeting m⁶A machinery are emerging.
• These strategies include small molecules, ASOs, and gene editing tools.
• Modulating m⁶A offers potential for cancer treatment.

Conclusions:

• Targeting m⁶A machinery presents a promising therapeutic avenue for cancer.
• Restoring m⁶A homeostasis or manipulating its dynamics can be beneficial.
• Further research is needed to optimize these strategies for clinical application.